Skip to main content
Clinical Trials/NCT04869384
NCT04869384
Completed
Phase 4

Effect of Electronic Monitoring and Feedback on Adherence to Easyhaler Controller Medication in Patients With Asthma

Orion Corporation, Orion Pharma1 site in 1 country158 target enrollmentJune 23, 2021
ConditionsAsthma

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Asthma
Sponsor
Orion Corporation, Orion Pharma
Enrollment
158
Locations
1
Primary Endpoint
Mean weekly adherence to controller medication
Status
Completed
Last Updated
last year

Overview

Brief Summary

Effect of Electronic Monitoring and Feedback on Adherence to Easyhaler Controller Medication in Patients with Asthma

Registry
clinicaltrials.gov
Start Date
June 23, 2021
End Date
April 24, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Mean weekly adherence to controller medication

Time Frame: Weekly during each of the last 6 weeks of treatment

Adherence (percentage of doses taken of the doses prescribed) to controller medication during last six weeks of study

Study Sites (1)

Loading locations...

Similar Trials